SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR

Clinical trials for SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR explained in plain language.

Never miss a new study

Get alerted when new SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR trials appear

Sign up with your email to follow new studies for SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New scan could Fine-Tune cancer radiation therapy

Disease control Recruiting now

This study aims to see if a special type of PET scan (using Detectnet) can help doctors plan Lutathera radiation therapy more safely for patients with neuroendocrine tumors. Researchers will compare the new scan method against the current standard to see if it can better predict …

Matched conditions: SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR

Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR

Get alerted when new SOMATOSTATIN RECEPTOR-POSITIVE NEUROENDOCRINE TUMOR trials appear

New scan could Fine-Tune cancer radiation therapy